Smith & Nephew (SNN) Cash from Investing Activities (QoQ) (2009 - 2014)
Smith & Nephew (SNN) Cash from Investing Activities (QoQ) (2009 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1,698.97% |
| Mar 31, 2014 | 254.55% |
| Mar 31, 2013 | -243.10% |
| Jun 30, 2012 | 195.70% |
| Mar 31, 2012 | -610.74% |
| Dec 31, 2011 | -80.60% |
| Sep 30, 2011 | 32.32% |
| Jun 30, 2011 | -47.76% |
| Mar 31, 2011 | 9.46% |
| Dec 31, 2010 | -10.45% |
| Sep 30, 2010 | -157.69% |
| Jun 30, 2010 | 75.70% |
| Mar 31, 2010 | -212.63% |
| Dec 31, 2009 | 235.71% |
| Sep 30, 2009 | -147.30% |
| Jun 30, 2009 | 204.23% |